| Identification of seven loci affecting mean telomere length and their association with disease V Codd, CP Nelson, E Albrecht, M Mangino, J Deelen, JL Buxton, ... Nature genetics 45 (4), 422-427, 2013 | 687 | 2013 |
| Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge R Saxena, MF Hivert, C Langenberg, T Tanaka, JS Pankow, ... Nature genetics 42 (2), 142-148, 2010 | 642 | 2010 |
| LOX-1, OxLDL, and atherosclerosis A Pirillo, GD Norata, AL Catapano Mediators of inflammation 2013, 2013 | 427 | 2013 |
| Deficiency of the long pentraxin PTX3 promotes vascular inflammation and atherosclerosis GD Norata, P Marchesi, VK Pulakazhi Venu, F Pasqualini, A Anselmo, ... Circulation 120 (8), 699, 2009 | 289 | 2009 |
| Plasma resistin levels correlate with determinants of the metabolic syndrome GD Norata, M Ongari, K Garlaschelli, S Raselli, L Grigore, AL Catapano European journal of endocrinology 156 (2), 279-284, 2007 | 274 | 2007 |
| Leptin: adiponectin ratio is an independent predictor of intima media thickness of the common carotid artery GD Norata, S Raselli, L Grigore, K Garlaschelli, E Dozio, P Magni, ... Stroke 38 (10), 2844-2846, 2007 | 219 | 2007 |
| The long pentraxin PTX3: a modulator of the immunoinflammatory response in atherosclerosis and cardiovascular diseases GD Norata, C Garlanda, AL Catapano Trends in cardiovascular medicine 20 (2), 35-40, 2010 | 175 | 2010 |
| Dihydrotestosterone decreases tumor necrosis factor-α and lipopolysaccharide-induced inflammatory response in human endothelial cells GD Norata, G Tibolla, PM Seccomandi, A Poletti, AL Catapano The Journal of Clinical Endocrinology & Metabolism 91 (2), 546-554, 2006 | 173 | 2006 |
| Long pentraxin 3, a key component of innate immunity, is modulated by high-density lipoproteins in endothelial cells GD Norata, P Marchesi, A Pirillo, P Uboldi, G Chiesa, V Maina, ... Arteriosclerosis, Thrombosis, and Vascular Biology 28 (5), 925-931, 2008 | 160 | 2008 |
| Emerging role of high density lipoproteins as a player in the immune system GD Norata, A Pirillo, E Ammirati, AL Catapano Atherosclerosis 220 (1), 11-21, 2012 | 155 | 2012 |
| Anti-inflammatory and anti-atherogenic effects of cathechin, caffeic acid and trans-resveratrol in apolipoprotein E deficient mice GD Norata, P Marchesi, S Passamonti, A Pirillo, F Violi, AL Catapano Atherosclerosis 191 (2), 265-271, 2007 | 155 | 2007 |
| Markers of inflammation associated with plaque progression and instability in patients with carotid atherosclerosis E Ammirati, F Moroni, GD Norata, M Magnoni, PG Camici Mediators of inflammation 2015, 2015 | 144 | 2015 |
| Proprotein convertase subtilisin/kexin type 9 (PCSK9): From structure–function relation to therapeutic inhibition G Tibolla, GD Norata, R Artali, F Meneghetti, AL Catapano Nutrition, Metabolism and Cardiovascular Diseases 21 (11), 835-843, 2011 | 141 | 2011 |
| Effector memory T cells are associated with atherosclerosis in humans and animal models E Ammirati, D Cianflone, V Vecchio, M Banfi, AC Vermi, M De Metrio, ... Journal of the American Heart Association 1 (1), e000125, 2012 | 140 | 2012 |
| Circulating CD4+CD25hiCD127lo Regulatory T-Cell Levels Do Not Reflect the Extent or Severity of Carotid and Coronary Atherosclerosis E Ammirati, D Cianflone, M Banfi, V Vecchio, A Palini, M De Metrio, ... Arteriosclerosis, thrombosis, and vascular biology 30 (9), 1832-1841, 2010 | 140 | 2010 |
| HDL in innate and adaptive immunity AL Catapano, A Pirillo, F Bonacina, GD Norata Cardiovascular research 103 (3), 372-383, 2014 | 135 | 2014 |
| Post-prandial endothelial dysfunction in hypertriglyceridemic subjects: molecular mechanisms and gene expression studies GD Norata, L Grigore, S Raselli, L Redaelli, A Hamsten, F Maggi, ... Atherosclerosis 193 (2), 321-327, 2007 | 130 | 2007 |
| The cellular and molecular basis of translational immunometabolism GD Norata, G Caligiuri, T Chavakis, G Matarese, MG Netea, A Nicoletti, ... Immunity 43 (3), 421-434, 2015 | 126 | 2015 |
| New therapeutic principles in dyslipidaemia: focus on LDL and Lp (a) lowering drugs GD Norata, CM Ballantyne, AL Catapano European heart journal 34 (24), 1783-1789, 2013 | 120 | 2013 |
| Targeting PCSK9 for hypercholesterolemia GD Norata, G Tibolla, AL Catapano Annual review of pharmacology and toxicology 54, 273-293, 2014 | 115 | 2014 |
